Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies
Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 2871-2876
DOI: 10.1021/acs.molpharmaceut.5c01659 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 15.04.2026. Verfasst von Mikolaj Milewski und 4 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, New Jersey 07065, United States. Hauptthemen laut MEDLINE: Antibodies, Monoclonal. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Merck.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merck & Co., Inc., Rahway, New Jersey 07065, United States.
ORCID-Profile: Mikolaj Milewski, Mikhail Murashov, Yash Kapoor
Förderung
- Merck
Zitieren
APA
Milewski, M., Cueto, M. A., Murashov, M., Kapoor, Y., & Alidori, S. (2026). Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies. Molecular Pharmaceutics, 23(5), 2871-2876. https://doi.org/10.1021/acs.molpharmaceut.5c01659
Vancouver
Milewski M, Cueto MA, Murashov M, Kapoor Y, Alidori S. Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies. Molecular Pharmaceutics. 2026;23(5):2871-2876. doi:10.1021/acs.molpharmaceut.5c01659
BibTeX
@article{Milewski2026,
author = {Milewski, Mikolaj and Cueto, Maria A and Murashov, Mikhail and Kapoor, Yash and Alidori, Simone},
title = {Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {5},
pages = {2871--2876},
doi = {10.1021/acs.molpharmaceut.5c01659}
}
EUVIMED